David Hurman

524 total citations
10 papers, 358 citations indexed

About

David Hurman is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David Hurman has authored 10 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Otorhinolaryngology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in David Hurman's work include Head and Neck Cancer Studies (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). David Hurman is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). David Hurman collaborates with scholars based in United Kingdom, United States and Australia. David Hurman's co-authors include Jason M. Kidd, A. Gibson, N. McMillan, Patrick Statham, Pamela Levack, John D. Graham, Robin Grant, R. Rampling, D A Collie and Dominic M. Summers and has published in prestigious journals such as Radiotherapy and Oncology, The Journal of Laryngology & Otology and European Archives of Oto-Rhino-Laryngology.

In The Last Decade

David Hurman

9 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hurman United Kingdom 7 201 106 95 93 88 10 358
Kalevi Hyrynkangas Finland 11 171 0.9× 96 0.9× 27 0.3× 153 1.6× 85 1.0× 18 338
J TERRELL United States 6 188 0.9× 134 1.3× 24 0.3× 189 2.0× 96 1.1× 9 435
Rebecca Green United States 10 152 0.8× 123 1.2× 20 0.2× 219 2.4× 105 1.2× 19 406
Peter C. de Jong Netherlands 9 262 1.3× 124 1.2× 32 0.3× 101 1.1× 44 0.5× 16 346
Christian Helmus United States 10 199 1.0× 95 0.9× 26 0.3× 84 0.9× 154 1.8× 17 386
Aydın Yavuz Türkiye 10 92 0.5× 130 1.2× 40 0.4× 42 0.5× 81 0.9× 33 326
Shahida Ahmed Canada 11 158 0.8× 146 1.4× 67 0.7× 12 0.1× 200 2.3× 33 436
Ashok M. Shenoy India 9 148 0.7× 143 1.3× 21 0.2× 148 1.6× 178 2.0× 40 398
Juan Alcalde Spain 12 191 1.0× 131 1.2× 17 0.2× 116 1.2× 125 1.4× 53 386
L. Holden Canada 11 249 1.2× 178 1.7× 76 0.8× 13 0.1× 161 1.8× 20 469

Countries citing papers authored by David Hurman

Since Specialization
Citations

This map shows the geographic impact of David Hurman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hurman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hurman more than expected).

Fields of papers citing papers by David Hurman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hurman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hurman. The network helps show where David Hurman may publish in the future.

Co-authorship network of co-authors of David Hurman

This figure shows the co-authorship network connecting the top 25 collaborators of David Hurman. A scholar is included among the top collaborators of David Hurman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hurman. David Hurman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hurman, David, et al.. (2015). Sequential Wide Field Irradiation and Systemic Chemotherapy as Part of the Induction Treatment of Small Cell Lung Cancer1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 168–175.
2.
Karlsson, Therese, et al.. (2013). Survival outcome depending on different treatment strategies in advanced stages III and IV laryngeal cancers: an audit of data from two European centres. European Archives of Oto-Rhino-Laryngology. 271(3). 547–554. 19 indexed citations
3.
Macfarlane, Tatiana V., et al.. (2012). Head and Neck Cancer Pain: Systematic Review of Prevalence and Associated Factors. Journal of Oral and Maxillofacial Research. 3(1). e1–e1. 60 indexed citations
5.
Trinidade, Aaron, et al.. (2011). Traditional and complementary and alternative medicines make for unwilling bedfellows in the management of cancer: a case report with a tragic outcome. The Journal of Laryngology & Otology. 125(11). 1193–1195. 4 indexed citations
6.
Hurman, David, et al.. (2011). Do GP referral guidelines really work? Audit of an electronic urgent referral system for suspected head and neck cancer. European Archives of Oto-Rhino-Laryngology. 269(5). 1509–1512. 11 indexed citations
7.
Levack, Pamela, John D. Graham, D A Collie, et al.. (2002). Don't Wait for a Sensory Level – Listen to the Symptoms: a Prospective Audit of the Delays in Diagnosis of Malignant Cord Compression. Clinical Oncology. 14(6). 472–480. 162 indexed citations
8.
Grant, David G., Aamir Hussain, & David Hurman. (1999). Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy. The Journal of Laryngology & Otology. 113(9). 829–833. 32 indexed citations
9.
Robertson, Chris, et al.. (1998). Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis. Radiotherapy and Oncology. 48(2). 165–173. 46 indexed citations
10.
Hurman, David, et al.. (1982). ADVERSE REACTION TO A RADIONUCLIDE BRAIN-SCANNING AGENT. Nuclear Medicine Communications. 3(6). 373–376. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026